Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan D Vo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brainRobert M Prins, Dan D Vo, Haumith Khan-Farooqi, et al.
International Immunology|December 25, 2008
Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigenChengyi J Shu, Caius G Radu, Stephanie M Shelly, et al.
Journal of Translational Medicine|June 21, 2012
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapyJon G Quatromoni, Yue Wang, Dan D Vo, et al.
Plos Genetics|February 5, 2019
Conformational regulation of Escherichia coli DNA polymerase V by RecA and ATPMalgorzata M Jaszczur, Dan D Vo, Ramunas Stanciauskas, et al.
Plos Genetics|March 27, 2015
A RecA protein surface required for activation of DNA polymerase VAngela J Gruber, Aysen L Erdem, Grzegorz Sabat, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2008
Immunosensitization with a Bcl-2 small molecule inhibitorJonathan Begley, Dan D Vo, Lilah F Morris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2008
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brainRobert M Prins, Chengyi J Shu, Caius G Radu, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Broad antitumor protection by dendritic cells administered to CD8alpha knock out miceAntoni Ribas, Dan D Vo, David L Weeks, et al.
Cancer Research|October 29, 2009
Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824Dan D Vo, Robert M Prins, Jonathan L Begley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
NK and CD4 cells collaborate to protect against melanoma tumor formation in the brainRobert M Prins, Dan D Vo, Haumith Khan-Farooqi, et al.
International Immunology|December 25, 2008
Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigenChengyi J Shu, Caius G Radu, Stephanie M Shelly, et al.
Journal of Translational Medicine|June 21, 2012
T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapyJon G Quatromoni, Yue Wang, Dan D Vo, et al.
Plos Genetics|February 5, 2019
Conformational regulation of Escherichia coli DNA polymerase V by RecA and ATPMalgorzata M Jaszczur, Dan D Vo, Ramunas Stanciauskas, et al.
Plos Genetics|March 27, 2015
A RecA protein surface required for activation of DNA polymerase VAngela J Gruber, Aysen L Erdem, Grzegorz Sabat, et al.
Cancer Immunology, Immunotherapy : CII|September 23, 2008
Immunosensitization with a Bcl-2 small molecule inhibitorJonathan Begley, Dan D Vo, Lilah F Morris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade)Lana Y Schumacher, Dan D Vo, Hermes J Garban, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2008
Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brainRobert M Prins, Chengyi J Shu, Caius G Radu, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2005
Broad antitumor protection by dendritic cells administered to CD8alpha knock out miceAntoni Ribas, Dan D Vo, David L Weeks, et al.
Cancer Research|October 29, 2009
Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824Dan D Vo, Robert M Prins, Jonathan L Begley, et al.
Pageof 1